DelveInsight’s Botulism market report thoroughly explains the Botulism historical and forecasted epidemiology and the Botulism market trends in the 7MM.
Key Highlights from the Botulism Market Report
-
According to the CDC, approximately 145 cases of botulism are reported in the United States each year. Botulism poisoning kills 3 to 5% of those who get it.
-
As per the CDC reports, 65% of Botulism cases occur in infants or children under the age of one year. Foodborne botulism accounts for approximately 15% of botulism cases.
-
As per Firych et al. (2020), according to ECDC epidemiological reports, botulism notification rates in the European Union have been low for the past 10 years.
-
Leading companies in the Botulism market include Xoma and others.
-
Key Botulism therapies in the pipeline include NTM-1633 and others.
Request for a sample to know more @ Botulism Market Outlook
Botulism Overview
Botulism (or botulism poisoning) is a rare but deadly illness spread through food, contact with contaminated soil, or an open wound. Botulism can cause paralysis, breathing difficulties, and death if not treated promptly.
Botulism Epidemiology Segmentation
The Botulism report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
-
Botulism Total Incident Cases
-
Botulism Cases by Transmission Category
-
Botulism Cases by Toxin Type
-
Botulism Diagnosed and Treatable Cases
Botulism Treatment Landscape
The current Botulism treatment option includes:
-
Antitoxins
-
Antibiotics
-
botulism immune globulin
-
Botulism Antitoxin Heptavalent
Botulism Market Outlook
According to Delveinsight, key companies’ increased Botulism Incidence and anticipated launch of emerging therapies will increase Botulism market size during the forecast period (2021-30).
Get a detailed analysis of the market @ Botulism Market Analysis
Botulism Pipeline Therapies and Key Companies
-
NTM-1633: Xoma
Table of Contents
| 1. | Key Insights |
| 2. | Botulism: Market Overview at a Glance |
| 3. | Executive Summary |
| 4. | Organizations |
| 5. | Patient Journey |
| 6. | Disease Overview: Botulism |
| 7. | Epidemiology and Patient Population |
| 8. | Unmet Needs |
| 9. | Emerging Therapies |
| 10. | Botulism: Market Outlook |
| 11. | Market Drivers |
| 12. | Market Barriers |
| 13. | Market access and Reimbursement |
| 14. | SWOT Analysis |
| 15. | Case studies |
| 16. | KOL Views |
| 17. | Appendix |
| 18. | Disclaimer |
| 19. | About DelveInsight |
Get in touch with our business executive for Healthcare Due Diligence Services
Related Reports
Get a comprehensive analysis of Botulism pipeline therapies and key companies, including XOMA, CytoDel, AlphaVax, PanThera Biopharma, among others.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/
